
Roche, Zealand Pharma strike $5.3bn weight-loss drug deal
The largest deal in the burgeoning weight-loss drugs market, worth up to $5.3 billion, has been struck between the Swiss pharma giant Roche and a Danish biotechnology company. Roche and Zealand Pharma have agreed a collaboration and licensing agreement to …